Results of myeloablative allogenic stem cell transplant (SCT) for severe sickle cell disease (SCD) in France.

被引：0
|
作者：
Bernaudin, F
Vernant, JP
Vilmer, E
Souillet, G
Vannier, JP
Bordigoni, P
Thuret, I
Fischer, A
Bertrand, Y
Lutz, P
Duval, M
Kuentz, M
Loic, L
Plouvier, E
Stephan, JL
Margueritte, G
de Montalembert, M
Benkerrou, M
Bories, D
Gluckman, E
机构：
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：5A / 5A
页数：1
相关论文
共 50 条
  • [41] Equivalent disease free and overall survival in lymphoma patients treated with either myeloablative (MA) or now myeloablative (NMA) conditioning and allogeneic stem cell transplant(SCT)
    Tomblyn, MR
    Brunstein, C
    Burns, LJ
    Miller, JS
    Tan, Y
    Weisdorf, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 113 - 114
  • [42] Transition in Sickle Cell Disease (SCD) - Recommendations of the German Sickle Cell Disease Transition Initiative
    Boell, J.
    Alashkar, F.
    Aramayo-Singelmann, C.
    Hoferer, A.
    Jarisch, A.
    Kamal, H.
    Oevermann, L.
    Schwarz, M.
    Cario, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 323 - 324
  • [43] A severe case of delayed transfusion reaction in a patient with sickle cell disease while preparing for allogeneic stem cell transplant
    Amit, Michelle
    Barsotti, Kellie
    Carll, Timothy
    Desai, Ami V.
    Kaviany, Saara
    PEDIATRIC BLOOD & CANCER, 2024, 71 (08)
  • [44] A SINGLE CENTER EXPERIENCE USING MYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR β-THALASSEMIA AND SICKLE CELL DISEASE
    Shyr, David
    Leung, Kathryn
    Krance, Robert
    Kennedy-Nasser, Alana
    Martinez, Caridad
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1022 - 1022
  • [45] Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease: Myeloablative Versus Reduced Intensity Conditioning
    Alsultan, Abdulrahman S.
    Basher, Enas
    Abujoub, Rodaina
    Essa, Mohammed F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S222 - S223
  • [46] Post-Transplant Cyclophosphamide Improves Engraftment in Patients with Sickle Cell Disease (SCD) and Severe Organ Damage who Undergo Haploidentical Peripheral Blood Stem Cell Transplantation (PBSCT)
    Fitzhugh, Courtney
    Hsieh, Matthew
    Taylor, Tiffani
    Coles, Wynona
    Luznik, Leo
    Powell, Jonathan
    Tisdale, John F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S319 - S319
  • [47] LONG TERM ORGAN STABILITY AND OUTCOME IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE (SCD) FOLLOWING REDUCED TOXICITY CONDITIONING (RTC) ALLOGENEIC STEM CELL TRANSPLANTATION (SCT)
    Bhatia, M.
    Geyer, M. B.
    Baker, C.
    Zuckerman, W. A.
    Duffy, D.
    Satwani, P.
    George, D.
    Garvin, J. H.
    Harrison, L.
    Baxter-Lowe, L. A.
    Schwartz, J.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S180 - S181
  • [48] The Incidence of CMV Infection and Disease in Pediatric Allogenic Stem Cell Transplant Recipients
    Singhal, Tanu
    Mehrotra, Juhi
    Sheth, Keval
    Davar, Namita
    Sen, Santanu
    INDIAN JOURNAL OF PEDIATRICS, 2023, 90 (12): : 1262 - 1262
  • [49] The Incidence of CMV Infection and Disease in Pediatric Allogenic Stem Cell Transplant Recipients
    Tanu Singhal
    Juhi Mehrotra
    Keval Sheth
    Namita Davar
    Santanu Sen
    Indian Journal of Pediatrics, 2023, 90 : 1262 - 1262
  • [50] Non-myeloablative stem cell transplantation for sickle cell anemia.
    Khan, MA
    Yu, LC
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S293 - S293
12345